ANG Lifesciences India Limited Share Price
ANG Lifesciences India Limited Returns Calculator
About ANG Lifesciences India Limited
ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. It operates in two segments, namely pharmaceuticals and printing and packaging. The Company's product portfolio includes various products comprising therapeutic categories, such as Antibiotics, Antiviral, Antimalarial, Antiulcer, Carbapenem, Corticosteroid, Penicillin and Beta Lactamase Inhibitor. The Company’s product category includes Dry Powder Injection, Liquid Injections, Hard Gelatin Capsule, Tablet Beta Lactum, Tablets, Liquid Suspension /Syrup, Ointment/Creams, and Soft Gelatin Capsule. Its Dry Powder Injection products include Ampicillin & Cloxacillin for injection 500mg, Azetronam for Injection USP 500mg, Ampicillin Injection 1.0gm, Ceftriaxone Injection 250mg, Amoxycillin & Potassium Clavulanate for injection 1.2gm, and others.
ANG Lifesciences India Limited Financial Highlights
- Revenue: ANG Lifesciences India Limited reported revenue of ₹93.43 crore in FY26 vs ₹94.86 crore in FY25. It showed a decrease of 1.51% on a yearly basis.
- Operating Profit: ANG Lifesciences India Limited reported an operating loss of ₹13.01 crore in FY26 vs ₹15.70 crore in FY25. It showed an increase of 17.13% on a year-on-year basis.
- Net Profit: ANG Lifesciences India Limited reported a net loss of ₹11.08 crore in FY26 vs ₹12.41 crore in FY25. It showed an increase of 10.72% on a yearly basis.
ANG Lifesciences India Limited Quarterly Result Highlights
- ANG Lifesciences India Limited reported revenue of ₹15.41 crore in Jun 2026, compared with ₹23.67 crore in Mar 2026, representing a decrease of 34.90% on a quarter-on-quarter (QoQ) basis.
- ANG Lifesciences India Limited reported an operating loss of ₹5.58 crore in Jun 2026, compared with ₹1.10 crore in Mar 2026, representing a decrease of 407.27% on a quarter-on-quarter (QoQ) basis.
- ANG Lifesciences India Limited reported a loss of ₹4.24 crore in Jun 2026, compared with ₹1.38 crore in Mar 2026, reflecting a decrease of 207.25% on a QoQ basis.
- The earnings per share (EPS) of ANG Lifesciences India Limited stood at ₹9.42 during Jun 2026.
| Jun 2025 | 0.00% |
|---|---|
| Sep 2025 | 0.00% |
| Dec 2025 | 0.00% |
| Mar 2026 | 0.00% |
ANG Lifesciences India Limited Shareholder Returns
ANG Lifesciences India Limited Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,63,180.00 | 38.28 | 5.55 | 13.74% | 0.61 | 17.33% | 93.24 | 0.83% | 0.48 | 10.90 |
| Divis Laboratories | 2,43,302.00 | 83.79 | 14.62 | 15.32% | 0.00 | 19.56% | 629.49 | 0.32% | 0.55 | 98.19 |
| Torrent Pharmaceuticals | 1,88,623.00 | 88.29 | 22.64 | 25.49% | 1.69 | 13.85% | 222.76 | 0.68% | 0.49 | 58.70 |
| Zydus Lifesciences | 1,16,114.00 | 25.00 | 4.24 | 18.59% | 0.31 | 17.35% | 237.30 | 0.09% | 0.33 | 35.38 |
| Cipla | 1,14,554.00 | 34.02 | 3.32 | 11.27% | 0.00 | 14.95% | 423.36 | 0.92% | 0.45 | 43.52 |
| Laurus Labs | 1,00,660.00 | 92.32 | 18.99 | 16.77% | 0.40 | 16.14% | 97.20 | 0.11% | 0.67 | 13.72 |
| Lupin | 98,312.20 | 17.73 | 4.38 | 23.76% | 0.04 | 24.88% | 659.00 | 0.84% | 0.57 | 129.18 |
| Dr. Reddy's Laboratories | 96,906.30 | 30.44 | 2.55 | 11.07% | 0.18 | 12.54% | 377.95 | 0.69% | 0.41 | 38.68 |
| Mankind Pharma | 97,467.00 | 47.54 | 6.03 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.44 | 49.37 |
| Aurobindo Pharma | 96,836.10 | 25.68 | 2.52 | 9.25% | 0.19 | 11.76% | 394.82 | 0.24% | 0.38 | 41.58 |
ANG Lifesciences India Limited Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹92.85 | ₹146.11 | ₹219.89 | ₹354.30 |
| Other Income | ₹2.02 | ₹0.70 | ₹9.72 | ₹0.90 |
| Total Revenue | ₹94.87 | ₹146.81 | ₹229.61 | ₹355.20 |
| Total Expenses | ₹110.57 | ₹155.79 | ₹226.99 | ₹301.70 |
| Profit Before Tax | -₹15.70 | -₹10.71 | ₹2.63 | ₹53.50 |
| Tax | -₹3.29 | -₹0.57 | ₹2.89 | ₹13.18 |
| Profit After Tax | -₹12.41 | -₹10.14 | -₹0.26 | ₹40.32 |
| EPS - Basic | -₹9.42 | -₹7.61 | ₹0.36 | ₹39.09 |
| EPS - Diluted | -₹9.42 | -₹7.61 | ₹0.36 | ₹39.09 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹15.70 | -₹10.71 | ₹2.63 | ₹53.50 |
| Income before WC changes | -₹2.25 | ₹9.18 | ₹23.32 | ₹70.30 |
| Change in Assets | ₹9.72 | ₹10.86 | ₹7.05 | -₹75.62 |
| Change in Liabilities | -₹3.50 | -₹16.12 | -₹0.53 | ₹30.57 |
| Change in WC | ₹6.22 | -₹5.27 | ₹6.51 | -₹45.05 |
| Cash flow from Operations | -₹0.26 | -₹9.49 | ₹26.38 | ₹24.72 |
| Cash flow from Investing | -₹1.59 | ₹19.89 | -₹9.33 | -₹44.41 |
| Cash flow from Financing | ₹1.68 | -₹10.40 | -₹17.07 | ₹19.93 |
| Total Cash Flow | -₹0.16 | -₹0.01 | -₹0.02 | ₹0.23 |
| Cash (Start of the year) | ₹0.32 | ₹0.32 | ₹0.35 | ₹0.11 |
| Cash (End of the year) | ₹0.16 | ₹0.32 | ₹0.32 | ₹0.35 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹68.56 | ₹69.13 | ₹94.51 | ₹98.22 |
| Current Assets | ₹161.03 | ₹173.31 | ₹183.15 | ₹192.81 |
| Total Assets | ₹229.59 | ₹242.44 | ₹277.66 | ₹291.03 |
| Current Liabilities | ₹143.44 | ₹144.57 | ₹162.28 | ₹166.29 |
| Net Current Asset | ₹17.59 | ₹28.75 | ₹20.87 | ₹26.52 |
| Non-Current Liabilities | ₹22.18 | ₹21.59 | ₹29.16 | ₹40.97 |
| Equity Capital | ₹63.98 | ₹76.28 | ₹86.22 | ₹83.77 |
| Total Equity & Liabilities | ₹229.59 | ₹242.44 | ₹277.66 | ₹291.03 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹89.91 | ₹131.37 | ₹207.01 | ₹348.67 |
| Other Income | ₹2.44 | ₹0.84 | ₹9.84 | ₹0.95 |
| Total Revenue | ₹92.35 | ₹132.20 | ₹216.85 | ₹349.62 |
| Total Expenses | ₹105.29 | ₹139.34 | ₹214.78 | ₹296.56 |
| Profit Before Tax | -₹12.94 | -₹8.87 | ₹2.07 | ₹53.06 |
| Tax | -₹2.59 | -₹0.22 | ₹2.73 | ₹13.35 |
| Profit After Tax | -₹10.34 | -₹8.65 | -₹0.66 | ₹39.71 |
| EPS - Basic | -₹7.86 | -₹6.48 | ₹0.04 | ₹38.51 |
| EPS - Diluted | -₹7.86 | -₹6.48 | ₹0.04 | ₹38.51 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹12.94 | -₹8.87 | ₹2.07 | ₹53.06 |
| Income before WC changes | -₹1.19 | ₹8.59 | ₹20.40 | ₹67.89 |
| Change in Assets | ₹9.41 | ₹8.29 | ₹12.72 | -₹65.35 |
| Change in Liabilities | -₹6.33 | -₹16.61 | -₹3.76 | ₹25.43 |
| Change in WC | ₹3.09 | -₹8.32 | ₹8.96 | -₹39.92 |
| Cash flow from Operations | -₹2.29 | -₹13.13 | ₹26.01 | ₹27.39 |
| Cash flow from Investing | -₹1.63 | ₹20.02 | -₹9.35 | -₹42.50 |
| Cash flow from Financing | ₹3.92 | -₹7.00 | -₹16.75 | ₹15.29 |
| Total Cash Flow | -₹0.01 | -₹0.12 | -₹0.08 | ₹0.17 |
| Cash (Start of the year) | ₹0.09 | ₹0.20 | ₹0.29 | ₹0.11 |
| Cash (End of the year) | ₹0.08 | ₹0.09 | ₹0.20 | ₹0.29 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹62.10 | ₹59.05 | ₹84.30 | ₹87.12 |
| Current Assets | ₹146.57 | ₹158.37 | ₹168.21 | ₹181.57 |
| Total Assets | ₹208.67 | ₹217.43 | ₹252.51 | ₹268.68 |
| Current Liabilities | ₹125.37 | ₹125.90 | ₹146.36 | ₹153.92 |
| Net Current Asset | ₹21.19 | ₹32.48 | ₹21.85 | ₹27.65 |
| Non-Current Liabilities | ₹16.49 | ₹14.46 | ₹20.62 | ₹31.28 |
| Equity Capital | ₹66.81 | ₹77.07 | ₹85.54 | ₹83.48 |
| Total Equity & Liabilities | ₹208.67 | ₹217.43 | ₹252.51 | ₹268.68 |
| 2 Sep | 0L |
|---|---|
| 1 Sep | 0L |
| 31 Aug | 0L |
| 28 Aug | 0L |
| 27 Aug | 0L |
| Average | 0L |
Popular Stocks
ANG Lifesciences India Limited Share Price FAQs
What is ANG Lifesciences India Limited share price today?
ANG Lifesciences India Limited share price is ₹32.78 as on 02 Sep, 2026, 15:15 IST.
How has the ANG Lifesciences India Limited share price performed in the past?
In the last 1 year, ANG Lifesciences India Limited delivered a return of 33.20%. The ANG Lifesciences India Limited share price hit a high of ₹49.69 and low of ₹17.63.
How much is the Mutual Fund shareholding in ANG Lifesciences India Limited shares?
The Mutual Fund Shareholding in ANG Lifesciences India Limited was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of ANG Lifesciences India Limited shares ?
The 52-week high and low of ANG Lifesciences India Limited share is ₹49.69 and ₹17.63 as of 02 Sep, 2026.
What is the market cap of ANG Lifesciences India Limited?
The market capitalisation of ANG Lifesciences India Limited is ₹42.81 Crores as on 02 Sep, 2026.
What are the stock symbols of ANG Lifesciences India Limited?
The stock symbol of ANG Lifesciences India Limited is 540694 on the BSE, and the ISIN is INE236W01016.
What was yesterday's closing price for ANG Lifesciences India Limited shares ?
ANG Lifesciences India Limited shares closed yesterday at ₹32.78 on BSE
How to buy ANG Lifesciences India Limited shares?
To buy ANG Lifesciences India Limited shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy ANG Lifesciences India Limited shares on Holidays?
No, shares of ANG Lifesciences India Limited or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell ANG Lifesciences India Limited shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of ANG Lifesciences India Limited?
The PE and PB ratio of ANG Lifesciences India Limited is -3.21 and 0.81 respectively, as on 02 Sep, 2026, 15:15 IST.